hg_117446.1

Basic information about the TSS

---

TSS ID: hg_117446.1 Species: human Chr: chr11		Start: 125569405 End: 125569489 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000524723.5 ENST00000615917.4 ENST00000534546.5 ENST00000618552.4 ENST00000620753.4 ENST00000529765.5 ENST00000527842.6 ENST00000531636.5 ENST00000278903.11 ENST00000527235.6 AB209820 AK301556 AK296620 AK223029 AK315841 AK316539 AK291951 Distance: 0 GeneID: 9538 HGNC/MGI_ID: HGNC:13276 UniProt_ID: A0A024R3I8 A0A087WV44 B4DWJ0 B7ZB74 E9PK61 E9PM05 E9PS58 O14681 Q59EJ1

Gene_name: EI24 autophagy associated transmembrane protein Gene_symbol: EI24 Gene_synonyms: EPG4 PIG8 TP53I8 Gene_source: HGNC:13276

TATA-Box annotation

---

Distance to TSS:	-30
Nearest PromoterID:	NM_001290135
Entrez ID:	9538
Nearest Unigene:	Hs.643514
Nearest Refseq:	NM_004879
Nearest Ensembl:	ENSG00000149547
Gene Name:	EI24 autophagy associated transmembrane protein
Gene Alias:	EPG4|PIG8|TP53I8
Gene Description:	EI24 autophagy associated transmembrane protein
Gene Type:	protein-coding
CpG%:	0.125
GC%:	0.766169
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@EI24 p2@EI24 p3@EI24
Sample		p1@EI24	p2@EI24	p3@EI24
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	58.25	5.26	2.34
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	60.49	6.88	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	61.15	5.79	2.31
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	48.24	2.49	3.12
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	49.04	4.50	2.92
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	47.68	4.26	2.71
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	69.07	6.10	2.83
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	47.96	5.57	2.91
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	61.55	4.27	4.06
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	22.03	2.32	1.74
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	20.62	3.64	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	21.95	3.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	19.83	2.90	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	23.76	2.10	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	18.88	4.39	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	16.60	3.52	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	17.04	2.62	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	19.40	2.95	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	15.46	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	20.91	1.65	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	18.44	2.94	1.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	18.47	4.14	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	18.87	2.71	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	18.69	2.67	1.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	17.80	2.84	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	13.61	5.06	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	12.64	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	21.93	2.59	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	15.18	2.42	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	16.29	2.17	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	18.21	4.40	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	17.00	3.71	0.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	19.20	3.17	1.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	21.77	3.79	1.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	19.26	3.37	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	18.40	4.22	0.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	21.05	4.29	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	19.75	3.22	1.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	17.56	5.40	1.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	18.72	3.84	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	21.64	3.53	0.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	20.79	3.07	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	22.78	2.53	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	22.90	2.80	1.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	19.27	3.21	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	16.98	3.95	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	20.39	4.56	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	17.29	2.68	0.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	21.30	3.83	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	20.02	2.83	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	17.63	3.89	1.02
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	20.01	2.67	0.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	15.26	3.55	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	21.54	2.65	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.85	5.87	3.36
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	24.80	5.05	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	20.09	2.27	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	15.09	2.57	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	22.00	4.71	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	17.63	2.82	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	20.75	2.80	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	31.05	7.17	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	18.69	4.08	0.34
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	19.50	3.25	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	21.65	2.84	1.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	47.38	39.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	23.40	0.49	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	26.78	1.98	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	26.27	1.88	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	22.85	1.32	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	25.37	0.62	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	23.85	1.53	0.00
Adipocyte - breast, donor1	11376-118A8	34.69	3.48	2.38
Adipocyte - breast, donor2	11327-117E4	30.96	3.53	2.09
Adipocyte - omental, donor1	11473-119C6	34.73	2.67	1.53
Adipocyte - omental, donor2	11474-119C7	14.95	1.49	2.99
Adipocyte - omental, donor3	11475-119C8	25.79	1.34	0.67
Adipocyte - perirenal, donor1	11476-119C9	21.69	1.91	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	11.00	1.10	2.20
Adipocyte - subcutaneous, donor2	11336-117F4	30.71	3.16	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	31.45	4.17	2.09
Adipocyte differentiation, day04, donor1	13019-139D4	24.64	1.96	2.74
Adipocyte differentiation, day04, donor2	13022-139D7	16.21	0.51	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	23.70	1.67	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	15.28	1.18	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	51.88	5.79	1.29
Adipocyte differentiation, day08, donor2	13023-139D8	20.66	2.90	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	24.53	5.33	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	18.36	1.67	1.67
Adipocyte differentiation, day12, donor1	13021-139D6	45.75	3.74	2.08
Adipocyte differentiation, day12, donor2	13024-139D9	21.35	2.51	1.26
Adipocyte differentiation, day12, donor3	13027-139E3	26.51	6.87	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	28.62	1.83	1.83
Alveolar Epithelial Cells, donor1	11510-119G7	44.20	3.76	2.21
Alveolar Epithelial Cells, donor2	11590-120G6	25.46	3.94	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	14.38	1.20	3.59
Amniotic Epithelial Cells, donor1	11533-120A3	37.24	2.52	1.08
Amniotic Epithelial Cells, donor2	11613-122A2	21.76	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	28.15	2.47	2.88
Anulus Pulposus Cell, donor1	11248-116E6	21.51	3.66	0.69
Anulus Pulposus Cell, donor2	11463-119B5	18.12	1.22	1.47
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	17.97	0.90	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	19.54	2.17	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	4.28	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	20.92	1.20	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	16.44	5.06	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	14.52	1.32	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	12.35	0.97	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	23.79	0.97	1.46
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	17.82	1.19	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	18.46	1.51	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	15.96	1.45	2.90
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	30.09	2.51	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	28.17	2.64	1.32
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	16.38	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	19.15	2.11	1.96
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	16.07	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	13.98	0.76	0.94
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	21.12	1.34	1.87
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	15.61	4.88	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	18.58	1.00	1.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	24.01	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	17.70	3.54	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	20.93	2.06	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	0.00	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	18.45	0.49	1.46
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	17.83	1.90	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	15.75	1.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	19.95	1.71	1.14
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	19.45	2.14	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	17.03	1.03	0.77
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	15.48	1.88	0.94
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	18.01	2.57	2.25
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	14.27	3.57	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	10.53	1.75	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	15.66	0.90	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	24.95	5.94	3.56
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	13.73	2.03	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	19.10	3.57	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	13.34	1.91	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	20.71	0.43	0.86
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	17.57	2.33	1.06
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	14.50	1.45	0.87
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	16.06	1.89	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	17.63	3.05	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	13.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	16.90	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	12.86	1.72	1.29
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	12.03	1.80	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	13.12	0.73	2.19
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	22.53	2.76	1.38
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	12.75	0.00	2.55
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	20.59	1.02	1.02
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	17.13	2.06	1.24
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	17.14	2.45	1.84
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	16.25	2.87	0.96
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	19.29	1.11	1.33
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	13.73	1.53	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	12.19	2.22	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	19.33	3.97	2.12
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	18.54	1.82	0.00
Astrocyte - cerebellum, donor1	11500-119F6	30.46	4.67	1.84
Astrocyte - cerebellum, donor2	11580-120F5	31.32	3.59	1.37
Astrocyte - cerebellum, donor3	11661-122F5	17.20	1.89	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	32.42	6.27	2.44
Astrocyte - cerebral cortex, donor2	11316-117D2	34.94	6.63	0.97
Astrocyte - cerebral cortex, donor3	11392-118C6	42.21	4.33	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	25.69	1.26	0.92
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	25.93	2.51	1.25
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	23.67	1.14	0.91
Basophils, donor1	12241-129G9	6.02	0.26	0.00
Basophils, donor2	12242-129H1	11.91	1.08	1.44
Basophils, donor3	12243-129H2	7.94	0.44	0.15
Bronchial Epithelial Cell, donor1	11511-119G8	30.18	3.23	0.86
Bronchial Epithelial Cell, donor2	11591-120G7	24.23	0.46	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	28.69	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	41.43	2.51	2.51
Bronchial Epithelial Cell, donor5	11457-119A8	40.97	2.91	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	22.57	2.07	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	27.89	1.08	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	33.08	5.05	1.13
Burkitt's lymphoma cell line:RAJI	10476-106I8	90.13	7.22	3.49
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	27.50	3.20	2.24
CD133+ stem cells - cord blood derived, pool1	12223-129E9	62.05	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	6.76	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	7.24	0.19	0.56
CD14+ Monocytes, donor3	11381-118B4	8.34	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	18.68	0.85	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	16.68	1.52	0.76
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	16.77	0.66	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	6.07	0.29	0.29
CD14+ monocytes - mock treated, donor2	11873-125C1	7.85	0.60	0.91
CD14+ monocytes - mock treated, donor3	11883-125D2	6.16	1.42	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	6.03	0.17	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	7.18	0.28	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	4.96	1.98	0.74
CD14+ monocytes - treated with BCG, donor1	11860-125A6	1.96	0.00	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	1.96	0.18	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	6.96	1.09	0.44
CD14+ monocytes - treated with Candida, donor1	11868-125B5	2.58	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	5.81	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	2.22	2.22	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.27	0.30	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	5.79	0.60	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	11.03	0.83	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	1.83	0.23	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	4.98	0.68	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	3.06	0.44	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	4.57	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	7.33	0.52	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	5.47	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	2.57	0.00	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	4.58	0.70	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	8.77	1.75	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	4.01	0.00	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	4.83	0.37	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	10.35	0.86	1.29
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	6.14	1.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	3.94	0.23	0.23
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	6.26	0.93	0.23
CD14+CD16+ Monocytes, donor1	11789-124B7	8.72	0.22	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	8.55	0.23	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	8.45	0.22	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	12.77	0.47	0.62
CD14+CD16- Monocytes, donor2	11799-124C8	10.30	0.00	0.52
CD14+CD16- Monocytes, donor3	11910-125G2	6.91	0.22	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	9.95	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	7.90	0.00	0.22
CD14-CD16+ Monocytes, donor3	11911-125G3	8.21	0.42	0.84
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	14.23	0.00	2.03
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	17.63	0.68	2.03
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	16.57	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	23.45	1.60	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	15.55	1.61	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	15.44	0.70	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	14.12	1.57	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	13.18	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	16.44	0.82	2.47
CD19+ B Cells, donor2	11624-122B4	15.23	0.73	0.00
CD19+ B Cells, donor3	11705-123B4	14.14	0.50	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	33.94	2.02	0.81
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	38.35	0.40	2.00
CD34+ Progenitors, donor1	11545-120B6	14.06	1.00	1.00
CD34+ Progenitors, donor2	11625-122B5	13.48	1.69	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	21.04	2.63	2.63
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	30.44	3.83	1.13
CD4+ T Cells, donor1	11225-116C1	27.49	0.36	1.79
CD4+ T Cells, donor2	11306-117C1	21.43	0.00	1.84
CD4+ T Cells, donor3	11382-118B5	21.65	0.30	1.52
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	22.46	1.02	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	17.74	0.45	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	21.85	0.29	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	27.97	0.00	2.84
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	34.41	0.70	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	9.89	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	14.16	1.01	0.72
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	20.00	0.68	0.51
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	12.74	0.32	1.13
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	22.41	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	17.47	0.00	0.35
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	14.96	0.44	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	19.82	1.26	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	12.47	0.21	1.04
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	16.37	0.33	1.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	21.21	0.82	0.82
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	36.44	1.07	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	0.00	1.79
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	19.66	1.11	1.67
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	19.28	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	20.17	0.63	0.63
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	18.71	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	24.70	0.43	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	15.69	0.44	1.31
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	26.72	0.49	2.47
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	18.46	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	36.29	2.79	2.79
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	20.77	1.38	1.66
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	26.75	0.98	1.23
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	24.64	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	21.85	1.43	1.07
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	16.62	1.38	2.77
CD8+ T Cells, donor1	11226-116C2	17.68	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	14.64	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	22.98	0.50	3.28
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	21.56	2.52	0.69
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	17.73	1.68	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	16.42	0.82	1.64
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	12.31	0.30	2.40
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	20.40	1.20	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	19.33	1.14	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	18.90	1.52	1.52
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	15.00	0.53	0.79
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	20.87	3.05	0.94
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	23.24	1.51	1.21
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	18.59	1.74	1.16
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	16.79	2.13	1.87
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	10.51	0.00	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	12.75	1.37	0.91
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	10.44	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	20.17	1.44	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	19.28	2.59	0.86
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	18.86	2.12	0.94
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	23.13	2.22	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	21.22	1.85	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	17.95	2.89	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	15.30	1.53	1.15
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	14.19	0.79	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	12.10	0.00	0.76
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	18.47	0.80	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	9.09	0.70	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	15.03	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	16.45	1.83	1.83
Cardiac Myocyte, donor2	11605-120I3	11.36	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	30.62	4.00	1.26
Chondrocyte - de diff, donor1	11261-116G1	22.88	4.85	1.73
Chondrocyte - de diff, donor2	11338-117F6	19.19	1.78	0.36
Chondrocyte - de diff, donor3	11410-118E6	19.68	2.05	1.59
Chondrocyte - re diff, donor2	11339-117F7	31.33	2.69	3.58
Chondrocyte - re diff, donor3	11411-118E7	26.29	2.02	0.81
Ciliary Epithelial Cells, donor1	11242-116D9	33.05	4.48	1.49
Ciliary Epithelial Cells, donor2	11323-117D9	24.58	3.21	1.71
Ciliary Epithelial Cells, donor3	11399-118D4	36.28	4.60	1.77
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	32.74	4.95	2.93
Corneal Epithelial Cells, donor1	11526-119I5	44.57	3.51	1.54
Corneal Epithelial Cells, donor2	11606-120I4	46.64	4.55	0.00
Corneal Epithelial Cells, donor3	11687-122I4	49.34	2.81	1.02
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	9.25	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	9.78	0.63	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	17.25	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	10.26	0.43	0.22
Dendritic Cells - plasmacytoid, donor1	11228-116C4	20.50	0.00	1.71
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	1.96	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	21.78	0.97	2.42
Endothelial Cells - Aortic, donor0	11207-116A1	42.53	5.67	1.83
Endothelial Cells - Aortic, donor1	11263-116G3	22.88	2.35	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	48.36	5.37	2.83
Endothelial Cells - Aortic, donor3	11412-118E8	45.61	4.33	1.97
Endothelial Cells - Artery, donor1	11264-116G4	30.54	2.62	1.16
Endothelial Cells - Artery, donor2	11341-117F9	39.29	5.18	1.65
Endothelial Cells - Artery, donor3	11413-118E9	45.05	5.08	1.05
Endothelial Cells - Lymphatic, donor1	11236-116D3	42.34	3.32	1.55
Endothelial Cells - Lymphatic, donor2	11317-117D3	33.77	3.35	0.61
Endothelial Cells - Lymphatic, donor3	11393-118C7	29.32	3.95	0.85
Endothelial Cells - Microvascular, donor1	11265-116G5	29.71	7.73	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	28.12	3.64	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	27.65	3.12	1.28
Endothelial Cells - Thoracic, donor1	11266-116G6	46.41	6.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	33.02	2.62	2.10
Endothelial Cells - Umbilical vein, donor1	11243-116E1	65.60	5.09	2.24
Endothelial Cells - Umbilical vein, donor2	11324-117E1	38.89	2.82	1.96
Endothelial Cells - Umbilical vein, donor3	11400-118D5	61.67	3.54	1.95
Endothelial Cells - Vein, donor1	11267-116G7	38.68	4.55	1.14
Endothelial Cells - Vein, donor2	11344-117G3	34.23	4.19	2.79
Endothelial Cells - Vein, donor3	11416-118F3	53.23	7.22	1.88
Eosinophils, donor1	12244-129H3	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	4.95	0.00	0.00
Eosinophils, donor3	12246-129H5	7.13	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	33.47	1.95	2.20
Esophageal Epithelial Cells, donor2	11587-120G3	22.88	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	21.35	2.87	2.87
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	28.90	2.85	1.20
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	31.63	2.93	1.08
Fibroblast - Aortic Adventitial, donor1	11245-116E3	38.93	6.31	1.21
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	8.60	2.18	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	23.31	2.53	0.53
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	7.64	0.53	0.26
Fibroblast - Aortic Adventitial, donor3	11401-118D6	38.54	1.33	1.33
Fibroblast - Cardiac, donor1	11268-116G8	18.15	3.18	0.45
Fibroblast - Cardiac, donor2	11345-117G4	24.25	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	25.39	1.73	2.52
Fibroblast - Cardiac, donor4	11452-119A3	32.43	3.33	0.91
Fibroblast - Cardiac, donor5	11456-119A7	31.09	3.30	1.52
Fibroblast - Cardiac, donor6	11460-119B2	30.02	3.18	1.97
Fibroblast - Choroid Plexus, donor1	11492-119E7	25.99	4.29	1.61
Fibroblast - Choroid Plexus, donor2	11572-120E6	12.08	3.02	3.02
Fibroblast - Choroid Plexus, donor3	11653-122E6	23.44	0.00	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	30.21	2.08	1.85
Fibroblast - Conjunctival, donor3	11692-122I9	20.01	3.39	2.04
Fibroblast - Dermal, donor1	11269-116G9	27.94	1.41	1.64
Fibroblast - Dermal, donor2	11346-117G5	33.96	1.89	1.42
Fibroblast - Dermal, donor3	11418-118F5	37.47	2.18	4.11
Fibroblast - Dermal, donor4	11450-119A1	27.47	2.71	1.70
Fibroblast - Dermal, donor5	11454-119A5	38.03	1.57	1.05
Fibroblast - Dermal, donor6	11458-119A9	32.65	2.60	2.11
Fibroblast - Gingival, donor1	11237-116D4	36.86	2.92	1.87
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	19.91	3.41	1.31
Fibroblast - Gingival, donor2	11318-117D4	37.56	3.16	1.71
Fibroblast - Gingival, donor3	11394-118C8	26.59	1.93	1.26
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	18.70	4.16	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	14.45	2.82	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	26.50	2.03	2.49
Fibroblast - Gingival, donor6 (control)	11922-125H5	19.88	1.62	0.81
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	19.06	1.76	2.47
Fibroblast - Gingival, donor7 (control)	11924-125H7	22.38	2.49	1.02
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	22.36	3.14	1.64
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.90	3.18	2.63
Fibroblast - Gingival, donor9 (control)	11927-125I1	14.82	3.08	1.03
Fibroblast - Lung, donor1	11270-116H1	14.95	0.00	1.36
Fibroblast - Lung, donor2	11347-117G6	31.34	2.98	2.98
Fibroblast - Lung, donor3	11419-118F6	40.94	3.17	2.74
Fibroblast - Lymphatic, donor1	11506-119G3	52.48	4.17	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	23.78	6.99	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	13.43	0.28	0.84
Fibroblast - Mammary, donor1	11540-120B1	50.34	3.65	2.44
Fibroblast - Mammary, donor2	11620-122A9	27.96	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	35.74	5.96	5.96
Fibroblast - Periodontal Ligament, donor1	11238-116D5	46.17	4.46	1.36
Fibroblast - Periodontal Ligament, donor2	11319-117D5	39.29	3.19	0.91
Fibroblast - Periodontal Ligament, donor3	11395-118C9	32.43	2.75	1.84
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	12.59	0.00	0.76
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	19.71	2.70	0.81
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	19.37	1.51	1.28
Fibroblast - Pulmonary Artery, donor1	11250-116E8	49.08	6.41	2.21
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.78	2.03	2.24
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	35.41	2.67	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	28.86	1.19	2.37
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	6.35	0.40	0.60
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	24.51	3.55	0.89
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	30.55	4.73	1.58
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	7.22	0.90	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	21.37	1.94	0.86
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	3.80	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	25.10	2.63	1.48
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	7.42	1.20	0.80
Fibroblast - skin normal, donor2	11561-120D4	16.38	1.00	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	4.84	0.00	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	27.01	2.57	1.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	22.39	3.42	1.20
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	5.25	0.66	0.99
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	19.81	2.02	1.49
Fibroblast - skin walker warburg, donor1	11554-120C6	31.21	2.02	2.53
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	24.62	1.73	2.04
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	44.32	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	48.81	1.74	2.61
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	50.79	5.55	3.12
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	65.32	7.81	4.16
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	61.58	8.43	3.07
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	29.86	3.83	3.06
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	32.54	6.38	1.91
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	70.46	7.70	1.43
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	46.05	4.41	1.93
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	34.93	3.88	1.83
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	48.94	6.14	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	40.97	5.55	1.06
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	37.51	8.48	1.63
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	68.10	6.63	1.77
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	31.23	3.82	1.13
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	29.68	4.80	1.11
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	34.65	5.10	1.07
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	24.90	4.09	0.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	21.46	3.32	0.69
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	20.13	1.63	0.61
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	32.86	5.02	2.51
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	26.16	5.48	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	26.23	5.03	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	32.21	4.14	1.18
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	24.32	4.61	1.11
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	30.83	5.14	1.12
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	31.86	6.45	1.21
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	24.60	4.75	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	36.80	7.45	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	30.90	4.99	1.46
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	26.30	3.42	1.20
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	26.45	4.09	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	34.53	6.49	1.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	28.18	6.74	1.02
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	24.96	5.36	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	26.17	4.61	0.58
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	30.35	5.34	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	21.82	2.42	1.98
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	29.52	4.06	1.72
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	26.42	4.21	0.97
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	23.73	3.21	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	27.00	3.32	0.66
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	29.90	3.01	0.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	26.15	3.04	2.43
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	24.57	4.08	1.05
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	28.76	2.20	1.54
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	25.53	1.96	1.68
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	27.13	4.26	0.83
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	34.23	4.28	1.87
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	33.36	4.13	1.07
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	29.02	3.89	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	34.70	7.05	1.63
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	25.44	3.13	1.66
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	25.22	3.95	1.10
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	19.83	3.97	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	25.85	2.77	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	23.20	2.62	0.20
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	40.67	6.35	2.54
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	36.03	8.36	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	28.81	5.24	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	36.01	6.75	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	61.96	4.69	3.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	53.12	4.80	3.11
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	40.59	6.92	2.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	7.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	37.13	5.42	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	43.32	8.02	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	36.52	5.22	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	35.80	5.21	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	28.41	2.88	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	33.32	3.33	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	24.05	5.31	2.80
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	29.42	5.56	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	31.04	2.52	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	24.81	4.77	0.95
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	23.78	4.42	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	37.59	4.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	25.20	2.86	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	19.24	5.33	0.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	30.49	5.08	1.69
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	30.24	3.31	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	31.99	5.98	1.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	63.22	5.27	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	23.45	6.54	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	22.82	4.56	1.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	29.43	4.01	2.01
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	25.81	3.85	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	21.91	3.77	0.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	17.39	7.45	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	25.01	6.13	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	19.31	6.03	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.56	5.09	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	25.13	3.59	0.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	23.68	2.47	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	24.79	7.08	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	24.50	4.08	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	25.02	4.83	2.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	11.02	1.70	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	19.70	3.58	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	25.23	5.34	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	22.83	1.14	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	12.06	2.49	2.08
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	25.86	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	13.64	2.22	0.32
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	16.29	1.25	2.09
Hep-2 cells mock treated, biol_rep1	11898-125E8	45.02	4.29	3.48
Hep-2 cells mock treated, biol_rep2	11899-125E9	38.49	3.21	2.53
Hep-2 cells mock treated, biol_rep3	11900-125F1	42.54	3.19	3.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	39.13	3.06	2.08
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	41.05	2.79	2.79
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	39.61	2.15	3.23
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	35.49	2.62	2.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	39.80	2.40	2.40
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	34.60	1.92	1.92
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	44.77	3.92	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	25.97	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	15.86	0.00	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	34.21	3.88	1.06
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	23.25	2.18	2.91
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	23.08	2.45	1.40
Hepatocyte, donor1	11523-119I2	48.42	3.63	0.00
Hepatocyte, donor2	11603-120I1	29.09	5.39	2.15
Hepatocyte, donor3	11684-122I1	69.94	6.75	2.45
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	24.15	0.65	5.22
Intestinal epithelial cells (polarized), donor1	11246-116E4	75.33	9.61	2.97
Iris Pigment Epithelial Cells, donor1	11530-119I9	24.97	3.29	0.82
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	22.29	0.00	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	27.69	1.38	2.77
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	22.52	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	59.34	0.00	23.74
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	28.19	0.00	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	22.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	34.11	1.62	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	40.02	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	18.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	25.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	25.50	1.11	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	10.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	41.57	1.26	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	27.84	0.00	3.09
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	30.36	0.65	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	16.10	1.61	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	20.37	1.63	4.07
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	22.67	1.68	1.68
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	39.38	0.80	1.61
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	0.00	0.92
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	40.12	1.89	2.83
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	41.72	3.63	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	58.97	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	34.44	2.15	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	41.93	2.54	3.81
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	30.61	1.28	1.91
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	36.45	0.00	7.29
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	63.22	0.00	15.80
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	35.70	0.00	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	19.91	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	45.99	0.93	3.40
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	38.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	31.43	0.00	6.29
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	34.07	2.09	5.56
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	22.13	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	42.15	3.24	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	32.26	0.00	5.23
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	24.75	0.00	6.75
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	38.33	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	36.27	0.00	1.07
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	30.48	1.39	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	2.85	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	33.14	0.00	3.68
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	21.18	0.00	3.03
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	18.63	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	20.09	0.00	2.11
Keratinocyte - epidermal, donor1	11272-116H3	50.84	4.49	2.86
Keratinocyte - epidermal, donor2	11349-117G8	25.77	0.59	3.51
Keratinocyte - epidermal, donor3	11421-118F8	55.94	3.88	1.42
Keratinocyte - oral, donor1	11251-116E9	62.21	3.41	0.79
Keratocytes, donor1	11527-119I6	32.32	4.13	1.72
Keratocytes, donor2	11607-120I5	42.18	2.34	2.34
Keratocytes, donor3	11688-122I5	25.69	1.78	0.99
Krukenberg tumor cell line:HSKTC	10687-109F3	21.98	2.20	2.20
Lens Epithelial Cells, donor1	11529-119I8	23.73	2.16	1.08
Lens Epithelial Cells, donor2	11609-120I7	20.07	5.19	1.96
Lens Epithelial Cells, donor3	11690-122I7	22.40	3.13	2.02
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	35.34	5.69	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	29.30	3.07	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	34.00	4.41	2.05
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	26.35	2.69	2.15
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	29.94	2.84	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	24.58	3.02	1.73
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	24.21	2.87	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	27.05	3.79	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	26.60	3.52	0.99
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	18.59	2.37	1.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	27.73	1.94	1.74
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	28.14	2.78	2.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	26.13	3.48	1.74
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	27.43	3.34	2.15
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	26.37	2.75	1.51
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	22.79	2.16	0.92
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	29.93	1.25	1.25
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	27.08	2.93	1.10
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	22.38	4.28	0.99
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	25.48	4.69	0.88
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	25.64	2.24	1.49
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	28.13	2.42	1.94
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	25.31	1.35	0.81
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	23.46	3.18	1.51
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	22.81	3.63	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	27.22	3.35	1.26
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	24.96	4.51	1.65
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	25.45	2.06	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	26.15	3.20	1.51
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	22.80	2.76	1.59
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	20.84	2.91	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	24.48	3.97	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	22.05	3.22	2.23
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	21.10	4.44	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	18.78	2.47	0.49
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	25.57	3.16	2.34
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	19.30	1.29	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	27.69	2.74	0.91
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	31.07	2.80	1.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	25.60	3.56	1.78
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	21.81	4.36	1.45
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	25.52	3.27	1.09
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	25.78	4.66	1.43
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	34.63	4.25	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	22.60	4.00	0.71
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	36.38	6.06	1.86
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	21.00	1.79	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	21.48	2.39	2.09
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	4.53	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	14.58	3.84	2.30
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	15.59	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	12.27	0.85	1.27
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	16.18	1.41	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	15.46	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	13.08	1.19	2.38
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	16.29	1.36	2.04
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	15.41	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	13.51	0.90	0.90
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.70	0.54	1.08
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	16.43	0.00	1.03
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	18.35	0.35	1.41
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	9.99	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	12.23	1.02	1.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	14.41	0.27	1.33
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	13.42	0.76	0.94
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	12.27	0.61	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	15.49	0.82	1.63
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	13.95	0.83	2.29
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	15.97	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	15.46	1.03	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	20.03	1.16	1.45
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	15.54	1.20	0.30
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	16.04	0.55	2.21
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	15.55	1.41	1.41
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	13.64	0.37	1.48
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	13.82	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	16.50	0.38	1.15
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	13.02	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	12.31	1.64	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	13.10	0.45	1.36
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	10.77	0.72	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	17.93	0.75	0.75
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	13.38	1.11	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	18.09	0.43	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	17.13	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	9.66	0.67	1.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	15.08	1.21	2.41
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	9.95	2.13	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	12.37	0.34	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	0.54	0.54
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	15.19	0.74	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	0.00	2.33
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	11.64	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	13.20	0.40	1.20
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	15.26	0.00	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	21.46	1.53	2.30
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	13.81	0.00	0.99
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	9.41	0.94	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	11.56	0.50	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	14.87	0.45	1.35
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	8.61	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	11.13	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	17.60	1.56	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	10.56	0.00	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	16.09	0.52	0.52
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	14.44	0.00	1.31
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	18.45	0.56	1.68
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	8.83	0.88	1.77
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	10.41	0.77	1.93
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	7.09	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	12.98	1.44	2.40
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	11.13	0.40	0.80
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	9.72	1.22	1.22
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	4.84	0.69	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	12.92	0.38	1.52
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	10.84	1.03	2.07
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	13.91	1.21	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	15.85	0.95	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	12.26	0.00	1.60
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	11.49	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	12.34	0.00	1.03
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	16.98	1.41	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	13.62	1.70	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	16.22	0.00	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	14.09	0.00	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	12.94	0.42	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	14.40	1.39	1.86
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	12.04	0.67	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	15.50	1.60	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	13.34	0.81	2.42
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	13.77	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	5.33	0.00	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	15.39	1.71	1.71
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	14.57	0.77	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	12.04	0.55	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.82	0.89	3.12
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	21.06	1.04	1.30
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	0.00	0.66
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	16.63	2.08	2.08
Macrophage - monocyte derived, donor1	11232-116C8	14.59	0.68	1.14
Macrophage - monocyte derived, donor2	11313-117C8	9.54	0.73	0.37
Macrophage - monocyte derived, donor3	11389-118C3	13.89	0.52	0.66
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	61.60	10.09	2.66
Mallassez-derived cells, donor2	11929-125I3	47.69	12.20	2.85
Mallassez-derived cells, donor3	11930-125I4	69.49	14.73	4.03
Mammary Epithelial Cell, donor1	11273-116H4	56.60	3.99	0.90
Mammary Epithelial Cell, donor2	11350-117G9	66.31	2.32	2.32
Mammary Epithelial Cell, donor3	11422-118F9	48.39	4.49	1.75
Mast cell - stimulated, donor1	11487-119E2	12.20	0.68	0.00
Mast cell, donor1	11563-120D6	15.25	0.65	0.76
Mast cell, donor2	11565-120D8	11.00	0.89	0.89
Mast cell, donor3	11566-120D9	15.31	0.23	0.68
Mast cell, donor4	11567-120E1	11.88	1.77	0.53
Mast cell, expanded and stimulated, donor5	11940-126A5	15.19	0.67	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	15.18	0.58	0.58
Mast cell, expanded, donor5	11939-126A4	16.29	0.46	0.00
Mast cell, expanded, donor8	11941-126A6	15.06	1.00	1.00
Melanocyte - dark, donor1	11502-119F8	35.22	3.68	1.99
Melanocyte - dark, donor2	11582-120F7	21.80	3.81	2.42
Melanocyte - dark, donor3	11663-122F7	48.25	4.49	2.17
Melanocyte - light, donor1	11274-116H5	33.15	2.12	2.35
Melanocyte - light, donor2	11351-117H1	35.49	2.05	1.36
Melanocyte - light, donor3	11423-118G1	28.62	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.50	4.06	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	54.86	4.30	3.77
Melanocyte, donor3 (MC+3)	12837-137B2	53.57	2.68	1.87
Meningeal Cells, donor1	11493-119E8	46.65	6.82	1.74
Meningeal Cells, donor2	11573-120E7	35.65	4.40	1.32
Meningeal Cells, donor3	11654-122E7	44.34	5.30	2.45
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	42.20	3.71	2.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	25.66	2.31	2.01
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	6.57	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	17.01	2.62	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	29.42	2.15	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	23.72	3.60	1.69
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	0.50	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	41.97	3.74	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	41.64	0.73	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	30.90	1.64	1.43
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	21.19	1.66	1.66
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	20.07	2.97	1.49
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	28.29	2.50	1.32
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	15.43	0.89	1.19
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	4.67	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	36.50	2.56	2.56
Mesenchymal stem cells - adipose, donor0	11217-116B2	42.89	1.77	3.19
Mesenchymal stem cells - hepatic, donor0	11218-116B3	29.71	4.38	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	33.38	2.18	2.18
Mesothelial Cells, donor1	11247-116E5	25.99	3.45	1.06
Mesothelial Cells, donor2	12156-128G5	28.03	4.50	1.50
Mesothelial Cells, donor3	11402-118D7	28.62	2.89	1.23
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	12.15	1.35	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	13.30	0.25	0.49
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	13.55	0.59	0.88
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	20.74	3.46	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	11.78	0.31	1.24
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	11.20	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	18.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	9.26	0.50	0.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	11.17	1.40	0.47
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	19.47	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	9.96	0.20	0.61
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	9.90	0.79	1.58
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	7.96	0.88	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	11.78	0.76	0.76
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	10.53	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	6.58	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	10.13	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	7.15	0.60	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	10.06	1.68	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	4.01	0.25	0.50
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	8.79	0.24	0.48
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	8.85	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	5.99	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	7.15	0.42	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	4.89	0.41	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	8.37	0.21	0.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	10.67	0.67	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	6.35	0.88	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	8.11	0.51	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	9.94	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	5.71	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	11.76	0.29	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	9.81	1.09	1.09
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	5.29	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	7.60	0.40	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	5.48	0.00	1.37
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	6.51	0.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	14.27	4.08	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	12.70	1.75	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	12.14	1.10	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	13.45	1.28	1.28
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	9.92	1.24	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	7.65	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	24.31	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	11.28	1.03	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	5.69	0.88	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	12.07	0.71	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.91	1.68	0.84
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	9.14	1.66	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	12.24	1.17	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	10.86	0.30	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	10.43	0.42	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	7.22
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	9.24	0.92	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	10.24	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	6.08	0.41	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	10.11	0.52	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	9.44	0.00	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	8.89	1.91	0.64
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	5.34	0.27	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	10.48	0.30	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	6.92	0.28	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	7.96	0.96	0.96
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	10.84	0.22	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	11.00	0.38	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	8.52	0.85	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	8.36	1.47	0.25
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	14.34	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	6.47	0.88	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	9.23	0.00	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	5.77	0.00	0.82
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	6.55	0.60	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	17.82	0.00	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	11.50	0.33	0.33
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	12.62	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	12.06	0.40	0.79
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	9.31	1.86	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	15.40	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	7.72	0.27	0.53
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	14.59	1.24	0.68
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	12.52	0.74	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	9.89	0.37	0.73
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	9.33	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	10.69	1.07	1.07
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	19.32	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	14.14	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	12.23	0.42	0.84
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	17.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	4.45	0.64	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	7.55	3.02	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	57.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	22.84	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	19.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	27.36	3.66	0.86
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	19.86	2.61	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	28.03	2.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	28.80	1.25	0.83
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	28.90	3.23	1.52
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	22.34	4.79	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	19.72	0.00	2.72
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	44.10	1.84	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	24.27	2.09	0.42
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	32.08	2.56	1.16
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	17.02	2.43	1.08
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	13.88	1.89	1.05
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	66.81	11.13	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	21.34	2.48	1.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	16.51	3.52	1.35
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	20.40	1.81	1.59
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	18.29	2.78	0.65
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	14.58	2.92	1.64
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	23.34	3.18	2.12
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	22.81	2.40	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	22.64	3.28	1.64
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	23.58	1.63	0.65
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	15.35	0.88	0.71
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	24.61	1.41	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	22.99	1.38	2.30
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.10	1.61	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.76	3.45	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	60.68	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	16.04	1.78	0.45
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	22.02	0.00	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	20.65	1.42	0.95
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	30.05	3.00	1.72
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	36.11	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	19.33	2.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	11.27	0.90	1.35
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	20.24	1.98	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	23.22	2.79	1.86
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	27.62	3.78	0.38
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	21.51	1.30	1.63
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	19.61	1.31	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	15.83	2.26	0.45
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	14.11	1.76	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	26.59	0.66	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	23.31	2.98	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	17.61	3.06	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	22.99	3.33	2.42
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	12.38	1.33	1.33
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	17.62	1.36	2.71
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	56.20	5.11	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	30.48	3.05	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	21.72	1.57	1.26
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	21.79	0.30	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	0.00	1.58
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	29.47	3.40	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	55.64	5.06	0.00
Myoblast, donor1	11241-116D8	29.07	2.36	1.74
Myoblast, donor2	11322-117D8	27.04	2.49	2.88
Myoblast, donor3	11398-118D3	29.93	3.03	2.02
NK T cell leukemia cell line:KHYG-1	10777-110G3	9.78	1.02	0.15
Natural Killer Cells, donor1	11230-116C6	15.07	0.62	0.31
Natural Killer Cells, donor2	11311-117C6	15.68	1.21	1.51
Natural Killer Cells, donor3	11387-118C1	14.72	0.55	0.74
Neural stem cells, donor1	11275-116H6	36.29	6.17	1.81
Neural stem cells, donor2	11352-117H2	26.96	3.85	3.85
Neurons, donor1	11494-119E9	36.41	10.24	4.55
Neurons, donor2	11574-120E8	38.31	4.62	3.96
Neurons, donor3	11655-122E8	32.06	5.76	2.47
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	1.83	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	21.97	3.21	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	11.07	0.65	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	17.45	2.41	0.40
Olfactory epithelial cells, donor1	11933-125I7	15.28	0.69	1.65
Olfactory epithelial cells, donor2	11934-125I8	18.53	0.87	2.75
Olfactory epithelial cells, donor3	11935-125I9	17.48	1.25	1.14
Olfactory epithelial cells, donor4	11936-126A1	17.63	2.24	0.78
Oligodendrocyte - precursors, donor1	11496-119F2	37.31	4.81	1.20
Osteoblast - differentiated, donor1	11276-116H7	30.63	2.13	1.91
Osteoblast - differentiated, donor2	11353-117H3	21.72	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	18.00	1.86	1.24
Osteoblast, donor1	11277-116H8	28.14	5.47	1.37
Osteoblast, donor2	11354-117H4	24.58	2.11	4.21
Osteoblast, donor3	11426-118G4	50.30	5.51	3.20
Pancreatic stromal cells, donor1	11249-116E7	30.41	3.29	1.10
Pericytes, donor1	11491-119E6	13.35	2.11	0.56
Pericytes, donor2	11571-120E5	19.01	1.36	1.36
Pericytes, donor3	11652-122E5	33.98	3.46	0.81
Perineurial Cells, donor1	11499-119F5	34.58	3.05	1.24
Perineurial Cells, donor2	11579-120F4	24.93	2.21	2.39
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	13.39	0.32	0.96
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	10.28	0.24	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	13.59	0.26	0.78
Placental Epithelial Cells, donor1	11278-116H9	24.16	3.35	1.91
Placental Epithelial Cells, donor2	11355-117H5	33.27	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	30.63	3.93	2.16
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	27.21	3.16	0.32
Preadipocyte - breast, donor1	11467-119B9	24.01	4.31	1.88
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.96	1.17	0.91
Preadipocyte - breast, donor2	11328-117E5	26.34	2.93	2.25
Preadipocyte - omental, donor1	11468-119C1	32.61	2.56	2.24
Preadipocyte - omental, donor2	11329-117E6	22.70	2.18	2.18
Preadipocyte - omental, donor3	11403-118D8	37.67	4.15	1.72
Preadipocyte - perirenal, donor1	11469-119C2	29.53	1.97	2.95
Preadipocyte - subcutaneous, donor1	11279-116I1	31.02	3.69	0.92
Preadipocyte - subcutaneous, donor2	11356-117H6	32.58	3.54	1.24
Preadipocyte - subcutaneous, donor3	11428-118G6	37.12	2.38	3.41
Preadipocyte - visceral, donor1	11280-116I2	33.16	2.05	1.40
Preadipocyte - visceral, donor2	11357-117H7	16.57	2.76	0.00
Preadipocyte - visceral, donor3	11429-118G7	23.72	1.67	1.78
Prostate Epithelial Cells (polarized), donor1	11253-116F2	74.22	11.16	3.32
Prostate Epithelial Cells, donor2	11331-117E8	35.48	7.85	2.44
Prostate Epithelial Cells, donor3	11404-118D9	38.82	1.84	0.92
Prostate Stromal Cells, donor1	11254-116F3	37.36	6.83	1.25
Prostate Stromal Cells, donor2	11332-117E9	23.13	2.33	1.08
Prostate Stromal Cells, donor3	11405-118E1	27.32	3.55	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	31.02	3.28	2.55
Renal Cortical Epithelial Cells, donor2	11596-120H3	32.51	2.70	1.18
Renal Epithelial Cells, donor1	11517-119H5	22.32	3.04	1.01
Renal Epithelial Cells, donor2	11597-120H4	29.88	2.85	1.42
Renal Epithelial Cells, donor3	11678-122H4	36.63	3.28	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	42.21	3.40	2.04
Renal Glomerular Endothelial Cells, donor2	11594-120H1	51.21	4.04	2.43
Renal Glomerular Endothelial Cells, donor3	11675-122H1	29.75	3.55	3.11
Renal Glomerular Endothelial Cells, donor4	11783-124B1	10.65	1.33	1.33
Renal Mesangial Cells, donor1	11518-119H6	36.75	5.72	2.20
Renal Mesangial Cells, donor2	11598-120H5	30.10	5.02	0.63
Renal Mesangial Cells, donor3	11679-122H5	23.58	3.33	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	45.63	2.15	2.42
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	21.08	1.69	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	38.96	2.51	3.28
Retinal Pigment Epithelial Cells, donor0	11215-116A9	37.34	3.37	1.56
Retinal Pigment Epithelial Cells, donor1	11528-119I7	27.86	4.83	1.71
Retinal Pigment Epithelial Cells, donor2	11608-120I6	20.58	3.09	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	19.82	1.76	1.51
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	63.48	5.88	2.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	11.61	5.36	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	7.71	3.30	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	4.06	2.32	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	16.64	3.51	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	19.17	4.07	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	24.87	5.47	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	17.61	5.58	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	18.53	4.31	0.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	18.03	2.77	0.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	14.38	4.38	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	18.61	4.08	1.06
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	20.07	5.91	1.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	16.07	3.44	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	16.96	4.51	0.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	18.14	3.76	1.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	15.87	2.87	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	19.66	4.75	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	21.99	4.89	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	13.40	5.57	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	19.86	4.38	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	23.68	6.30	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	13.03	3.84	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	17.38	3.08	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	18.97	6.49	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	14.40	2.19	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	17.66	4.41	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	23.91	5.37	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	17.22	3.30	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	23.02	2.78	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	27.59	5.38	1.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	16.38	4.77	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	20.57	7.74	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	16.71	4.39	2.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	16.82	4.04	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	22.14	4.60	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	21.98	4.05	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	16.85	2.24	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	27.85	4.53	1.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	19.70	5.58	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	13.98	1.53	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	21.60	4.73	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	13.86	2.40	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	13.00	4.42	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.81	2.62	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	17.53	4.84	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	12.24	3.30	0.09
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	10.48	4.54	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	14.51	6.04	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	13.46	3.30	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	17.32	4.08	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	21.29	3.04	3.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	16.58	3.62	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	17.42	4.52	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	17.97	2.40	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	13.81	5.90	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	18.78	5.76	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	11.42	1.20	1.20
Schwann Cells, donor1	11498-119F4	28.77	3.57	2.07
Schwann Cells, donor2	11578-120F3	23.82	0.00	0.00
Schwann Cells, donor3	11659-122F3	25.41	1.75	1.53
Sebocyte, donor1	11220-116B5	77.78	6.03	4.38
Sebocyte, donor2	11301-117B5	51.01	9.65	4.60
Sebocyte, donor3	11378-118B1	44.93	2.68	2.68
Sertoli Cells, donor1	11255-116F4	43.07	4.97	1.66
Sertoli Cells, donor2	11333-117F1	14.12	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	24.19	2.99	1.58
Skeletal Muscle Cells, donor2	11358-117H8	12.29	3.61	0.00
Skeletal Muscle Cells, donor3	11430-118G8	35.95	6.69	4.18
Skeletal Muscle Cells, donor4	11451-119A2	37.86	1.89	1.57
Skeletal Muscle Cells, donor5	11455-119A6	35.67	3.12	2.23
Skeletal Muscle Cells, donor6	11459-119B1	38.01	3.23	0.92
Skeletal Muscle Satellite Cells, donor1	11240-116D7	34.15	2.65	2.39
Skeletal Muscle Satellite Cells, donor2	11321-117D7	34.82	2.85	2.14
Skeletal Muscle Satellite Cells, donor3	11397-118D2	52.58	4.27	2.18
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	24.85	3.20	2.02
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	17.37	2.90	2.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	18.30	2.89	1.65
Skin - palm, donor1	10286-104F7	37.61	2.69	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	45.55	3.60	2.16
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	21.27	1.64	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	46.87	5.32	1.82
Small Airway Epithelial Cells, donor1	11256-116F5	43.23	4.31	2.78
Small Airway Epithelial Cells, donor2	11334-117F2	29.26	2.67	1.13
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	30.87	5.07	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	43.77	2.85	1.87
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	26.85	0.93	1.23
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	4.67	0.89	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	31.15	1.18	0.59
Smooth Muscle Cells - Aortic, donor1	11283-116I5	24.09	3.54	1.77
Smooth Muscle Cells - Aortic, donor2	11360-117I1	24.41	2.76	2.36
Smooth Muscle Cells - Aortic, donor3	11432-118H1	30.13	0.77	4.64
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	1.00	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	23.69	2.40	0.80
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	23.27	2.44	1.11
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	67.98	4.74	2.56
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	30.61	3.58	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	33.08	4.43	2.66
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	36.02	2.99	1.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	28.63	2.11	1.63
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	18.87	3.04	1.52
Smooth Muscle Cells - Carotid, donor1	11285-116I7	23.74	4.29	1.77
Smooth Muscle Cells - Carotid, donor2	11362-117I3	36.72	12.24	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	23.84	1.91	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.07	3.10	0.88
Smooth Muscle Cells - Colonic, donor2	11320-117D6	22.60	3.66	0.65
Smooth Muscle Cells - Colonic, donor3	11396-118D1	39.88	3.25	1.68
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	34.34	2.32	2.78
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	37.73	1.08	2.16
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	30.18	1.20	1.20
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	28.68	3.07	1.37
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	25.99	2.98	1.81
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	42.97	6.64	3.52
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	23.21	3.87	1.14
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	15.70	0.00	0.60
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	51.66	6.36	1.59
Smooth Muscle Cells - Prostate, donor1	11257-116F6	23.70	1.46	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	26.80	2.88	1.88
Smooth Muscle Cells - Prostate, donor3	11465-119B7	23.34	1.78	0.76
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	38.45	2.11	1.36
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	17.25	0.75	2.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	95.62	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	30.23	1.40	4.19
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	34.84	1.51	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	25.38	1.88	1.25
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	31.27	1.18	2.36
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	39.49	2.67	1.83
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	19.62	0.93	1.40
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	37.56	2.59	1.87
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	34.93	6.12	2.04
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	22.94	2.82	0.56
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	22.08	2.52	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	27.06	2.85	1.68
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	8.10	0.48	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	31.56	2.45	1.22
Smooth Muscle Cells - Uterine, donor1	11258-116F7	31.37	3.09	1.55
Smooth Muscle Cells - Uterine, donor3	11466-119B8	16.68	2.05	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	16.13	1.94	1.75
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	17.98	1.32	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	7.81	1.12	1.12
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	25.87	1.80	1.08
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	23.28	3.69	1.99
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	13.79	2.36	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	12.70	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	17.97	1.20	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	10.03	1.25	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	21.08	2.75	0.46
Synoviocyte, donor1	11291-117A4	27.94	1.35	1.35
Synoviocyte, donor2	11368-117I9	21.12	2.68	1.68
Synoviocyte, donor3	11440-118H9	11.62	1.56	1.56
Trabecular Meshwork Cells, donor1	11532-120A2	52.53	5.36	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	15.86	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	19.22	1.39	1.16
Tracheal Epithelial Cells, donor1	11292-117A5	40.72	2.37	1.36
Tracheal Epithelial Cells, donor2	11369-118A1	31.31	1.93	1.16
Tracheal Epithelial Cells, donor3	11441-118I1	30.92	4.58	2.29
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	63.23	4.31	1.72
Urethra, donor2	10319-105A4	19.78	1.80	1.80
Urothelial Cells, donor1	11520-119H8	45.16	1.59	2.92
Urothelial Cells, donor2	11600-120H7	30.84	2.40	1.20
Urothelial Cells, donor3	11681-122H7	23.61	2.75	1.83
Urothelial cells, donor0	11216-116B1	48.81	2.90	1.11
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	0.00	0.89
Whole blood (ribopure), donor090309, donation2	12180-129A2	14.30	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	10.27	0.68	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	10.67	0.00	0.69
Whole blood (ribopure), donor090325, donation2	12177-128I8	10.46	0.00	1.16
Whole blood (ribopure), donor090612, donation1	12182-129A4	6.25	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	12.85	0.92	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	8.22	1.83	0.00
Wilms' tumor cell line:G-401	10809-111A8	78.46	5.18	4.81
Wilms' tumor cell line:HFWT	10597-108E3	30.80	7.04	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	37.71	3.07	2.23
achilles tendon, donor2	10292-104G4	28.93	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	54.82	6.37	2.55
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	47.36	5.34	2.32
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	23.15	2.02	1.78
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	49.80	3.54	5.17
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	27.27	4.78	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	22.21	2.96	3.17
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	28.04	4.90	1.63
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	27.76	2.20	1.76
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	28.99	1.63	4.90
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	48.54	3.88	3.11
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	41.95	3.13	3.86
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	39.01	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	39.50	7.67	2.79
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	61.88	5.70	3.37
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	58.45	4.38	2.63
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	39.04	1.39	3.25
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	11.93	1.65	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	99.14	3.38	7.37
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	70.41	2.99	5.55
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	63.39	3.64	4.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	70.53	3.13	3.85
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	34.08	3.12	1.56
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	26.35	1.00	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	27.87	1.86	3.72
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	93.04	11.68	10.17
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	38.38	3.93	6.11
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	28.12	3.75	3.75
adenocarcinoma cell line:IM95m	10796-110I4	53.93	3.77	1.41
adipose tissue, adult, pool1	10010-101C1	23.27	2.64	1.71
adipose, donor1	10184-103D4	62.75	9.97	2.35
adipose, donor2	10185-103D5	18.25	1.62	0.00
adipose, donor3	10186-103D6	33.49	3.54	0.82
adipose, donor4	10187-103D7	56.34	5.20	0.87
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	105.90	2.53	6.94
adrenal gland, adult, pool1	10081-102A9	14.55	0.00	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	6.40	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	41.80	1.07	2.14
amniotic membrane cells, donor1	12235-129G3	24.58	0.46	2.55
amniotic membrane cells, donor2	12236-129G4	35.84	1.69	4.06
amniotic membrane cells, donor3	12237-129G5	30.34	1.18	2.36
amygdala - adult, donor10196	10167-103B5	23.72	0.00	1.19
amygdala, adult, donor10252	10151-102I7	35.69	2.03	2.64
amygdala, newborn, donor10223	10360-105E9	26.79	0.97	2.58
anaplastic carcinoma cell line:8305C	10428-106D5	22.79	2.67	1.02
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	32.65	3.97	1.99
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	39.75	10.36	1.67
aorta, adult, pool1	10052-101G7	25.69	2.75	3.33
appendix, adult	10189-103D9	24.45	0.78	1.94
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	28.55	12.04	2.06
artery, adult	10190-103E1	28.53	2.72	4.08
astrocytoma cell line:TM-31	10425-106D2	44.62	9.71	1.88
b cell line:RPMI1788	10427-106D4	28.25	1.49	1.64
basal cell carcinoma cell line:TE 354.T	10702-109G9	36.90	4.16	1.39
bile duct carcinoma cell line:HuCCT1	10432-106D9	62.32	1.89	4.17
bile duct carcinoma cell line:TFK-1	10496-107C1	14.06	1.00	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	24.61	1.68	1.68
bladder, adult, pool1	10011-101C2	24.99	1.63	1.52
blood, adult, pool1	10053-101G8	8.86	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	23.12	1.71	0.86
bone marrow, adult	10192-103E3	18.90	2.70	1.35
brain, adult, donor1	10084-102B3	37.93	3.08	8.20
brain, adult, pool1	10012-101C3	25.72	1.34	2.56
brain, fetal, pool1	10085-102B4	37.40	5.34	8.01
breast carcinoma cell line:MCF7	10482-107A5	24.45	0.66	2.64
breast carcinoma cell line:MDA-MB-453	10419-106C5	44.19	2.62	2.37
breast, adult, donor1	10080-102A8	24.62	0.00	0.63
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	70.12	6.48	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	51.33	2.78	2.78
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	44.20	2.76	5.99
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	40.43	1.69	3.39
carcinoid cell line:NCI-H1770	10703-109H1	47.49	6.58	1.41
carcinoid cell line:NCI-H727	10735-110B6	56.88	6.02	2.84
carcinoid cell line:SK-PN-DW	10719-109I8	10.46	1.27	1.27
carcinosarcoma cell line:JHUCS-1	10642-109A3	18.63	7.19	2.66
caudate nucleus - adult, donor10196	10177-103C6	28.78	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	36.31	1.67	2.01
caudate nucleus, adult, donor10258	10379-105H1	43.56	1.53	3.82
caudate nucleus, newborn, donor10223	10354-105E3	26.00	1.46	3.30
cerebellum - adult, donor10196	10173-103C2	26.22	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	23.06	3.63	0.64
cerebellum, adult, pool1	10083-102B2	24.84	1.38	2.07
cerebellum, newborn, donor10223	10357-105E6	20.76	5.81	1.66
cerebral meninges, adult	10188-103D8	31.52	2.27	3.53
cerebrospinal fluid, donor2	10294-104G6	27.04	0.73	1.46
cervical cancer cell line:D98-AH2	10552-107I3	28.76	4.03	2.59
cervical cancer cell line:ME-180	10553-107I4	35.79	4.81	1.66
cervix, adult, pool1	10013-101C4	27.82	2.94	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	28.01	1.67	1.53
chondrosarcoma cell line:SW 1353	10700-109G7	14.37	2.61	1.31
choriocarcinoma cell line:BeWo	10423-106C9	37.78	2.36	2.86
choriocarcinoma cell line:SCH	10785-110H2	45.47	2.34	5.67
choriocarcinoma cell line:T3M-3	10618-108G6	17.31	2.85	1.42
chorionic membrane cells, donor1	12238-129G6	22.79	1.71	1.14
chorionic membrane cells, donor2	12239-129G7	26.55	3.48	0.80
chorionic membrane cells, donor3	12240-129G8	20.88	0.55	1.10
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	31.30	2.02	6.06
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	29.01	5.76	1.54
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	36.96	4.86	2.75
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	43.14	2.82	1.80
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	47.65	2.90	3.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	47.85	1.02	2.65
chronic myelogenous leukemia cell line:K562	10454-106G4	81.86	6.48	5.30
chronic myelogenous leukemia cell line:KU812	10409-106B4	43.26	3.39	3.13
clear cell carcinoma cell line:JHOC-5	10638-108I8	37.26	1.37	2.51
clear cell carcinoma cell line:TEN	10636-108I6	34.87	2.08	0.87
colon carcinoma cell line:CACO-2	10513-107D9	74.13	11.17	2.75
colon carcinoma cell line:COLO-320	10420-106C6	31.17	6.08	3.80
colon, adult, donor1	10082-102B1	45.22	1.19	2.38
colon, adult, pool1	10014-101C5	29.14	4.00	1.18
colon, fetal, donor1	10070-101I7	20.39	1.24	1.85
common myeloid progenitor CMP, donor1	12130-128D6	73.34	13.75	4.58
common myeloid progenitor CMP, donor2	12134-128E1	25.04	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	12.32	1.27	0.85
cord blood derived cell line:COBL-a 24h infection	10453-106G3	18.72	2.41	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	18.75	2.26	1.13
corpus callosum, adult, pool1	10042-101F6	38.81	3.54	3.76
cruciate ligament, donor2	10295-104G7	31.61	0.81	3.24
diaphragm, fetal, donor1	10069-101I6	26.48	4.01	0.00
diencephalon, adult	10193-103E4	17.52	1.20	1.68
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	29.16	2.07	1.61
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.54	4.36	3.08
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	39.96	2.41	1.20
ductus deferens, adult	10196-103E7	31.89	0.50	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	23.04	0.00	2.88
duodenum, fetal, donor1, tech_rep2	10071-101I8	30.16	5.15	2.94
dura mater, adult, donor1	10041-101F5	30.31	1.49	3.06
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	33.98	3.11	2.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	87.41	6.88	4.01
embryonic pancreas cell line:1B2C6	10604-108F1	26.51	0.62	1.85
embryonic pancreas cell line:1C3D3	10605-108F2	23.31	1.82	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.67	2.78	1.23
embryonic pancreas cell line:2C6	10603-108E9	26.27	2.63	1.31
endometrial carcinoma cell line:OMC-2	10497-107C2	29.83	5.36	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	44.77	1.99	3.08
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	39.40	3.38	1.13
epidermoid carcinoma cell line:A431	10426-106D3	13.89	1.56	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	33.33	2.20	1.32
epididymis, adult	10197-103E8	24.07	1.05	3.35
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	64.93	2.48	6.03
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	32.64	3.15	1.57
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.06	2.23	1.83
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	25.88	1.87	1.08
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	38.87	2.35	1.01
esophagus, adult, pool1	10015-101C6	30.69	0.96	1.38
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	61.62	6.64	4.13
eye - muscle inferior rectus, donor1	10272-104E2	50.71	0.00	7.24
eye - muscle lateral, donor2	10298-104H1	33.67	0.00	0.00
eye - muscle medial, donor2	10299-104H2	26.79	0.00	2.98
eye - muscle superior, donor2	10297-104G9	22.93	0.00	3.44
eye - vitreous humor, donor1	10268-104D7	27.69	0.00	0.00
eye, fetal, donor1	10054-101G9	24.41	2.29	2.29
fibrosarcoma cell line:HT-1080	10758-110E2	39.24	3.97	1.80
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	41.07	2.14	2.85
frontal lobe, adult, pool1	10040-101F4	36.69	2.53	3.38
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	46.24	4.20	3.30
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	32.37	1.37	0.91
gall bladder, adult	10198-103E9	31.39	1.93	2.66
gamma delta positive T cells, donor1	11937-126A2	17.18	1.07	0.00
gamma delta positive T cells, donor2	11938-126A3	14.57	0.75	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	18.59	1.69	1.27
gastric adenocarcinoma cell line:MKN45	10612-108F9	94.58	9.28	5.03
gastric cancer cell line:AZ521	10549-107H9	74.11	6.72	4.10
gastric cancer cell line:GSS	10560-108A2	30.20	1.83	1.83
gastrointestinal carcinoma cell line:ECC12	10615-108G3	15.76	3.20	1.14
giant cell carcinoma cell line:LU65	10487-107B1	23.98	1.49	2.52
giant cell carcinoma cell line:Lu99B	10433-106E1	19.73	0.98	1.82
glassy cell carcinoma cell line:HOKUG	10688-109F4	18.21	0.50	1.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	18.79	1.06	1.58
glioblastoma cell line:A172, tech_rep2	10444-106F3	16.57	1.54	1.69
glioblastoma cell line:T98G	10485-107A8	44.15	3.42	1.77
glioma cell line:GI-1	10413-106B8	20.50	2.93	2.34
globus pallidus - adult, donor10196	10175-103C4	32.07	3.64	2.19
globus pallidus, adult, donor10252	10161-103A8	32.22	1.95	1.71
globus pallidus, adult, donor10258	10367-105F7	19.17	0.00	1.37
globus pallidus, newborn, donor10223	10364-105F4	21.32	2.13	4.26
granulocyte macrophage progenitor, donor1	12131-128D7	95.44	4.89	4.89
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	18.56	2.24	2.24
hIPS +CCl2, biol_rep1	14383-156B9	31.22	2.30	0.46
hIPS +CCl2, biol_rep2	14384-156C1	24.69	1.83	0.46
hIPS +CCl2, biol_rep3	14385-156C2	27.05	1.29	0.00
hIPS, biol_rep1	14380-156B6	23.00	2.87	0.00
hIPS, biol_rep2	14381-156B7	22.63	2.06	0.69
hIPS, biol_rep3	14382-156B8	22.07	1.10	0.00
hairy cell leukemia cell line:Mo	10712-109I1	27.58	1.72	3.16
heart - mitral valve, adult	10205-103F7	24.81	1.20	0.30
heart - pulmonic valve, adult	10206-103F8	19.09	1.05	0.78
heart - tricuspid valve, adult	10207-103F9	54.12	2.50	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	45.91	2.04	1.84
heart, adult, diseased, donor1	10051-101G6	26.83	1.28	2.55
heart, adult, pool1	10016-101C7	32.43	1.15	2.53
heart, fetal, pool1	10046-101G1	29.37	5.85	2.16
hepatic mesenchymal tumor cell line:LI90	10778-110G4	33.01	3.09	1.85
hepatoblastoma cell line:HuH-6	10633-108I3	19.03	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	49.17	6.30	1.44
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	56.07	7.77	1.70
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	49.92	7.38	1.01
hepatoma cell line:Li-7	10484-107A7	21.02	3.23	1.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	25.63	3.12	1.51
hippocampus - adult, donor10196	10169-103B7	18.93	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	31.64	2.25	2.45
hippocampus, adult, donor10258	10374-105G5	16.43	0.50	1.00
hippocampus, newborn, donor10223	10363-105F3	25.73	0.35	2.11
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	80.57	8.54	2.44
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	45.95	6.09	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	53.57	5.59	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	37.22	5.64	2.82
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	31.50	2.84	1.81
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	31.13	5.69	3.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	31.24	4.38	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	31.67	3.88	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	38.79	6.26	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	37.65	8.05	1.66
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	25.88	5.30	0.64
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	41.74	6.06	1.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	49.76	5.63	2.66
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	39.79	4.42	1.47
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.02	6.11	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	36.46	4.01	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	27.47	4.80	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	29.99	5.50	1.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	21.10	3.01	1.51
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	20.01	1.82	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	16.60	2.82	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	23.03	4.25	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.06	2.32	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	22.42	3.89	2.09
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	31.96	3.69	1.11
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.66	3.42	1.43
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	64.92	9.39	2.45
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	36.62	5.28	1.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	32.62	5.07	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	37.83	8.17	2.72
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	24.30	3.62	2.59
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	28.56	5.31	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	21.04	5.13	1.80
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	24.29	3.83	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	23.47	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	27.22	5.04	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	35.50	5.07	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	45.01	5.79	0.45
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	38.54	5.37	1.46
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	31.78	6.11	2.44
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	74.82	13.01	3.25
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	42.03	7.94	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	25.18	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	35.46	2.17	2.17
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	26.33	3.91	2.14
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	17.90	3.58	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	40.63	7.31	2.30
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	29.09	4.85	2.16
immature langerhans cells, donor1	11904-125F5	36.81	2.66	2.91
immature langerhans cells, donor2	11905-125F6	29.31	1.58	1.58
insula, adult, pool1	10039-101F3	44.38	2.46	3.41
keratoacanthoma cell line:HKA-1	10791-110H8	18.53	3.58	0.65
kidney, adult, pool1	10017-101C8	30.14	2.60	1.30
kidney, fetal, pool1	10045-101F9	30.56	6.01	2.26
large cell lung carcinoma cell line:IA-LM	10509-107D5	17.18	2.84	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	14.38	1.24	1.11
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	19.08	0.73	0.55
left atrium, adult, donor1	10079-102A7	19.07	1.09	0.54
left ventricle, adult, donor1	10078-102A6	22.25	0.51	0.51
leiomyoblastoma cell line:G-402	10721-110A1	73.33	4.10	3.56
leiomyoma cell line:10964C	10569-108B2	22.27	3.95	3.23
leiomyoma cell line:15242A	10570-108B3	17.93	0.00	1.09
leiomyoma cell line:15425	10571-108B4	17.24	2.43	1.94
leiomyosarcoma cell line:Hs 5.T	10722-110A2	19.05	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	25.09	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	14.29	3.07	0.83
liposarcoma cell line:KMLS-1	10782-110G8	24.21	1.56	0.94
liposarcoma cell line:SW 872	10726-110A6	56.53	6.21	2.31
liver, adult, pool1	10018-101C9	65.31	9.72	2.27
liver, fetal, pool1	10086-102B5	39.51	0.94	1.88
locus coeruleus - adult, donor10196	10182-103D2	18.23	1.17	1.17
locus coeruleus, adult, donor10252	10165-103B3	28.97	1.29	0.92
locus coeruleus, adult, donor10258	10375-105G6	29.91	1.97	1.41
locus coeruleus, newborn, donor10223	10362-105F2	17.25	1.68	1.26
lung adenocarcinoma cell line:A549	10499-107C4	16.05	0.97	1.80
lung adenocarcinoma cell line:PC-14	10408-106B3	28.96	2.07	1.38
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	47.59	3.43	1.05
lung, adult, pool1	10019-101D1	26.11	1.77	0.83
lung, fetal, donor1	10068-101I5	24.26	1.71	2.85
lung, right lower lobe, adult, donor1	10075-102A3	22.45	1.83	1.83
lymph node, adult, donor1	10077-102A5	18.46	0.95	0.95
lymphangiectasia cell line:DS-1	10727-110A7	39.67	3.51	1.75
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	20.38	8.30	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	31.43	3.40	1.70
mature adipocyte, donor1	12231-129F8	41.74	2.66	1.78
mature adipocyte, donor2	12232-129F9	34.03	1.25	3.32
mature adipocyte, donor3	12233-129G1	37.46	2.61	2.13
mature adipocyte, donor4	12234-129G2	30.27	2.90	1.84
maxillary sinus tumor cell line:HSQ-89	10414-106B9	40.50	3.34	3.81
medial frontal gyrus - adult, donor10196	10170-103B8	27.07	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	32.18	1.84	1.47
medial frontal gyrus, adult, donor10258	10368-105F8	23.19	1.59	4.13
medial frontal gyrus, newborn, donor10223	10352-105E1	27.30	2.13	3.41
medial temporal gyrus - adult, donor10196	10183-103D3	29.53	2.03	3.38
medial temporal gyrus, adult, donor10252	10156-103A3	32.26	1.91	0.64
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	0.00	3.85
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	28.71	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	29.43	1.79	4.67
medulla oblongata - adult, donor10196	10174-103C3	18.17	0.65	2.60
medulla oblongata, adult, donor10252	10155-103A2	24.77	0.62	1.39
medulla oblongata, adult, pool1	10038-101F2	31.67	3.35	3.02
medulla oblongata, newborn, donor10223	10361-105F1	18.75	0.35	1.74
medulloblastoma cell line:D283 Med	10838-111E1	27.23	2.21	2.66
medulloblastoma cell line:ONS-76	10759-110E3	32.77	3.91	1.10
melanoma cell line:COLO 679	10514-107E1	26.16	5.75	1.15
melanoma cell line:G-361	10465-106H6	19.55	4.61	1.09
meningioma cell line:HKBMM	10691-109F7	27.14	0.54	1.27
merkel cell carcinoma cell line:MKL-1	10843-111E6	50.23	6.17	6.17
merkel cell carcinoma cell line:MS-1	10844-111E7	48.99	16.59	2.07
mesenchymal precursor cell - adipose, donor1	11747-123G1	33.45	2.92	2.61
mesenchymal precursor cell - adipose, donor2	11748-123G2	14.72	3.09	2.00
mesenchymal precursor cell - adipose, donor3	11749-123G3	16.98	0.83	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	13.77	1.40	0.56
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	16.18	1.93	0.77
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	18.74	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	23.00	4.29	1.03
mesenchymal precursor cell - cardiac, donor2	11753-123G7	17.37	2.65	1.61
mesenchymal precursor cell - cardiac, donor3	11754-123G8	21.89	1.99	1.99
mesenchymal precursor cell - cardiac, donor4	11755-123G9	22.96	4.59	1.62
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	21.34	2.28	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	18.11	2.31	0.66
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	22.83	2.49	1.94
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	24.78	1.75	0.35
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	18.17	1.22	0.82
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	14.38	0.72	2.52
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	13.55	2.79	1.34
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	17.78	1.14	2.51
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	23.08	2.94	2.52
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	18.53	2.24	1.94
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	17.94	3.94	1.40
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	17.67	2.58	1.47
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	15.17	2.00	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	24.84	2.95	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	14.16	1.83	0.91
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	14.07	2.56	1.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	16.49	1.31	1.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	15.10	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	15.77	2.35	0.47
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	19.97	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	20.83	1.18	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	18.07	1.39	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	18.46	2.31	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	22.53	1.56	0.67
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	21.39	1.44	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	19.80	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	17.12	0.67	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	20.88	0.41	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	16.75	0.43	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	21.88	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	25.82	5.16	10.33
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	21.11	0.97	2.27
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	14.55	0.00	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	27.72	1.60	2.13
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	21.26	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	24.88	1.17	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	27.28	10.49	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	15.90	1.99	2.98
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	21.35	0.59	1.19
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	20.71	2.44	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	20.90	0.63	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	13.11	1.38	1.38
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	17.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	27.94	3.99	3.99
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	20.66	3.44	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	21.60	3.67	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	19.07	2.38	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	20.63	1.77	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	22.13	0.31	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	28.07	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	31.93	2.37	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	33.38	2.57	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	33.04	4.82	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	68.28	11.88	1.98
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	61.68	8.97	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	68.69	8.90	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	82.21	8.46	3.63
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	91.58	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	77.29	10.14	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	3.03	2.43
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	40.67	4.52	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	46.95	4.94	3.29
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	39.09	2.58	2.58
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	36.99	2.60	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	36.67	5.09	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	15.47	2.32	2.32
mesothelioma cell line:ACC-MESO-1	10493-107B7	35.91	2.36	2.60
mesothelioma cell line:ACC-MESO-4	10494-107B8	52.59	6.49	2.32
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	12.82	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	17.16	1.23	0.92
mesothelioma cell line:Mero-25	10850-111F4	24.28	2.50	0.45
mesothelioma cell line:Mero-41	10851-111F5	20.29	2.44	1.22
mesothelioma cell line:Mero-48a	10852-111F6	29.89	1.77	2.66
mesothelioma cell line:Mero-82	10853-111F7	10.25	2.10	0.53
mesothelioma cell line:Mero-83	10854-111F8	32.68	1.70	2.04
mesothelioma cell line:Mero-84	10855-111F9	32.86	3.79	1.77
mesothelioma cell line:Mero-95	10856-111G1	24.85	2.48	1.66
mesothelioma cell line:NCI-H2052	10847-111F1	47.04	3.64	3.15
mesothelioma cell line:NCI-H226	10846-111E9	47.78	3.08	3.08
mesothelioma cell line:NCI-H2452	10848-111F2	28.01	2.39	2.73
mesothelioma cell line:NCI-H28	10845-111E8	15.27	2.04	1.27
mesothelioma cell line:No36	10857-111G2	46.32	3.59	1.30
mesothelioma cell line:ONE58	10858-111G3	23.03	1.63	0.54
migratory langerhans cells, donor1	11901-125F2	7.29	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	11.23	0.73	0.49
migratory langerhans cells, donor3	11903-125F4	12.74	1.26	0.36
mixed mullerian tumor cell line:HTMMT	10689-109F5	26.77	1.96	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	16.53	0.42	0.42
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	55.29	1.84	2.99
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	16.75	1.33	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	31.05	4.44	2.03
myeloma cell line:PCM6	10474-106I6	11.46	0.40	0.20
myxofibrosarcoma cell line:MFH-ino	10600-108E6	9.13	0.51	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	20.40	0.39	0.98
nasal epithelial cells, donor1, tech_rep1	12226-129F3	39.67	2.79	1.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	43.46	2.72	1.62
nasal epithelial cells, donor2	12227-129F4	39.19	2.21	1.66
neuroblastoma cell line:CHP-134	10508-107D4	56.59	8.97	7.13
neuroblastoma cell line:NB-1	10539-107G8	45.27	7.67	2.81
neuroblastoma cell line:NBsusSR	10607-108F4	37.75	8.86	2.11
neuroblastoma cell line:NH-12	10555-107I6	17.52	2.98	1.12
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	21.35	3.08	5.22
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	41.81	5.54	5.07
neuroectodermal tumor cell line:TASK1	10774-110F9	83.52	11.87	5.23
neuroepithelioma cell line:SK-N-MC	10728-110A8	71.21	0.64	5.72
neurofibroma cell line:Hs 53.T	10729-110A9	27.95	3.99	1.60
neutrophil PMN, donor1	12133-128D9	29.75	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	28.07	4.06	1.35
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	38.42	4.80	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	23.40	3.85	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	19.18	3.68	1.05
nucleus accumbens, adult, pool1	10037-101F1	37.78	2.62	5.72
occipital cortex - adult, donor10196	10172-103C1	26.78	0.00	2.06
occipital cortex, adult, donor10252	10163-103B1	37.30	1.07	1.61
occipital cortex, newborn, donor10223	10355-105E4	24.75	1.09	4.37
occipital lobe, adult, donor1	10076-102A4	29.13	2.36	2.10
occipital lobe, fetal, donor1	10073-102A1	34.33	1.72	6.87
occipital pole, adult, pool1	10036-101E9	36.98	1.89	3.63
olfactory region, adult	10195-103E6	22.35	2.10	2.10
optic nerve, donor1	10277-104E7	42.02	2.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	35.99	5.47	2.62
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	33.11	3.43	1.10
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	16.09	2.54	1.35
oral squamous cell carcinoma cell line:SAS	10544-107H4	17.67	1.96	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	24.40	1.47	2.06
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	18.69	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	31.60	3.61	2.33
ovary, adult, pool1	10020-101D2	24.81	1.92	2.27
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	24.75	3.12	1.47
pancreas, adult, donor1	10049-101G4	61.14	5.64	2.82
pancreatic carcinoma cell line:NOR-P1	10698-109G5	32.99	4.75	2.24
papillary adenocarcinoma cell line:8505C	10437-106E5	34.58	2.04	1.02
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	29.14	3.81	1.32
paracentral gyrus, adult, pool1	10035-101E8	37.43	2.01	3.39
parietal cortex, adult, donor10258	10373-105G4	21.29	0.73	2.20
parietal lobe - adult, donor10196	10171-103B9	33.86	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	25.08	1.71	2.85
parietal lobe, adult, pool1	10034-101E7	40.89	2.38	3.61
parietal lobe, fetal, donor1	10072-101I9	22.31	2.91	5.82
parietal lobe, newborn, donor10223	10356-105E5	28.41	1.50	2.99
parotid gland, adult	10199-103F1	53.03	3.70	3.08
penis, adult	10200-103F2	25.78	2.15	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	20.27	0.74	5.21
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	36.28	5.97	2.04
pineal gland - adult, donor10196	10179-103C8	10.32	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	15.40	1.78	0.59
pineal gland, adult, donor10258	10377-105G8	16.93	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	19.22	1.01	3.04
pituitary gland, adult, donor10252	10162-103A9	30.75	3.13	0.52
pituitary gland, adult, donor10258	10378-105G9	21.28	0.85	1.70
placenta, adult, pool1	10021-101D3	21.29	2.58	1.51
plasma cell leukemia cell line:ARH-77	10840-111E3	21.06	2.12	1.06
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	18.05	1.09	0.16
pons, adult, pool1	10033-101E6	23.15	2.07	2.41
postcentral gyrus, adult, pool1	10032-101E5	41.58	3.31	4.10
promyelocytes/myelocytes PMC, donor1	12132-128D8	58.56	4.18	4.18
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	50.40	1.46	2.04
prostate cancer cell line:PC-3	10439-106E7	69.88	4.90	3.45
prostate, adult, pool1	10022-101D4	28.21	2.09	1.90
putamen, adult, donor10196	10176-103C5	33.28	2.12	3.07
putamen, adult, donor10252	10152-102I8	45.10	0.00	3.92
putamen, adult, donor10258, tech_rep1	10372-105G3	22.95	1.09	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	33.83	0.97	4.11
putamen, newborn, donor10223	10365-105F5	11.99	0.75	2.25
rectal cancer cell line:TT1TKB	10469-106I1	38.69	3.20	3.78
rectum, fetal, donor1	10067-101I4	33.38	5.56	13.91
renal cell carcinoma cell line:OS-RC-2	10411-106B6	39.43	4.03	3.39
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	46.81	0.41	0.83
retina, adult, pool1	10030-101E3	32.30	2.19	4.17
retinoblastoma cell line:Y79	10475-106I7	52.74	4.16	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	52.25	2.95	1.84
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	38.24	8.44	2.81
sacrococcigeal teratoma cell line:HTST	10695-109G2	18.19	2.27	0.76
salivary acinar cells, donor1	11771-123I7	25.57	0.81	0.81
salivary acinar cells, donor2	11772-123I8	30.84	1.38	2.20
salivary acinar cells, donor3	11773-123I9	25.82	0.00	0.66
salivary gland, adult, pool1	10093-102C3	40.61	7.44	2.86
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	36.42	5.14	2.02
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	40.79	4.23	2.23
seminal vesicle, adult	10201-103F3	24.34	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	18.71	0.97	1.46
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	22.90	2.01	3.27
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	24.08	5.02	2.01
serous cystadenocarcinoma cell line:HTOA	10693-109F9	17.86	4.16	0.81
signet ring carcinoma cell line:Kato III	10436-106E4	34.37	3.32	1.77
signet ring carcinoma cell line:NUGC-4	10483-107A6	44.90	3.10	3.48
skeletal muscle - soleus muscle, donor1	10282-104F3	51.07	2.84	4.26
skeletal muscle, adult, pool1	10023-101D5	32.62	1.80	2.28
skeletal muscle, fetal, donor1	10066-101I3	19.10	0.00	2.01
skin, adult, donor1	10074-102A2	40.71	0.00	0.00
skin, fetal, donor1	10065-101I2	25.25	1.89	1.26
small cell cervical cancer cell line:HCSC-1	10800-110I8	111.73	17.01	2.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	23.33	6.30	0.63
small cell lung carcinoma cell line:DMS 144	10841-111E4	26.98	1.73	2.12
small cell lung carcinoma cell line:LK-2	10541-107H1	35.11	4.45	1.32
small cell lung carcinoma cell line:NCI-H82	10842-111E5	28.31	2.73	1.13
small cell lung carcinoma cell line:WA-hT	10562-108A4	47.07	9.81	1.31
small intestine, adult, pool1	10024-101D6	40.73	3.22	1.91
small intestine, fetal, donor1	10064-101I1	21.13	1.23	2.46
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	23.59	1.54	0.00
smooth muscle, adult, pool1	10048-101G3	28.43	1.55	1.29
somatostatinoma cell line:QGP-1	10781-110G7	34.57	3.48	2.95
spinal cord - adult, donor10196	10181-103D1	23.40	2.06	1.84
spinal cord, adult, donor10252	10159-103A6	17.74	1.58	1.97
spinal cord, adult, donor10258	10369-105F9	13.14	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	30.49	2.44	3.66
spinal cord, newborn, donor10223	10359-105E8	16.07	1.38	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	24.34	2.84	1.19
spleen, adult, pool1	10025-101D7	20.60	1.87	0.88
spleen, fetal, pool1	10044-101F8	24.39	3.02	0.64
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	29.81	2.48	1.24
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	21.08	1.71	1.71
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	53.82	6.99	3.15
squamous cell carcinoma cell line:T3M-5	10616-108G4	54.34	1.17	1.95
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	87.68	7.99	6.75
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	30.92	0.85	0.42
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	42.73	3.38	0.42
stomach, fetal, donor1	10062-101H8	68.35	4.27	11.75
submaxillary gland, adult	10202-103F4	41.02	2.28	2.85
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	30.33	1.66	2.70
substantia nigra, adult, donor10258	10371-105G2	20.69	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	17.66	2.83	2.12
synovial sarcoma cell line:HS-SY-II	10441-106E9	69.47	5.27	5.04
temporal lobe, adult, pool1	10031-101E4	43.74	1.44	5.34
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	44.87	4.27	4.27
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	29.89	2.64	4.83
tenocyte, donor1	11763-123H8	18.85	1.05	2.79
tenocyte, donor2	11765-123I1	17.17	2.67	1.14
tenocyte, donor3	11768-123I4	20.39	0.00	1.11
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	39.09	7.99	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	37.92	4.32	2.00
teratocarcinoma cell line:PA-1	10807-111A6	60.29	9.76	4.18
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	17.77	4.82	0.63
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	16.26	1.89	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	13.20	6.22	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	17.26	1.95	0.65
testis, adult, pool1	10026-101D8	18.79	4.40	2.36
testis, adult, pool2	10096-102C6	28.87	8.57	2.26
thalamus - adult, donor10196	10168-103B6	19.87	2.21	2.21
thalamus, adult, donor10252	10154-103A1	29.54	1.88	0.94
thalamus, adult, donor10258, tech_rep1	10370-105G1	18.48	1.54	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	16.30	0.82	0.49
thalamus, newborn, donor10223	10366-105F6	13.81	1.73	2.30
throat, adult	10209-103G2	24.72	0.50	1.00
throat, fetal, donor1	10061-101H7	25.60	1.52	3.35
thymic carcinoma cell line:Ty-82	10803-111A2	43.52	4.17	4.57
thymus, adult, pool1	10027-101D9	20.58	1.89	2.19
thymus, fetal, pool1	10043-101F7	23.27	2.08	1.25
thyroid carcinoma cell line:KHM-5M	10776-110G2	13.03	1.46	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	44.98	3.35	3.07
thyroid, adult, pool1	10028-101E1	27.81	1.77	1.87
thyroid, fetal, donor1	10060-101H6	28.74	1.32	2.11
tongue epidermis (fungiform papillae), donor1	10288-104F9	40.04	0.00	3.08
tongue, adult	10203-103F5	25.12	1.86	1.63
tongue, fetal, donor1	10059-101H5	25.22	3.94	3.15
tonsil, adult, pool1	10047-101G2	32.56	2.10	1.80
trachea, adult, pool1	10029-101E2	31.25	2.04	2.45
trachea, fetal, donor1	10058-101H4	25.01	4.62	2.69
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	23.38	1.77	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	24.01	3.14	1.22
transitional-cell carcinoma cell line:JMSU1	10492-107B6	12.53	2.82	0.47
tridermal teratoma cell line:HGRT	10694-109G1	30.44	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	32.17	3.56	2.71
umbilical cord, fetal, donor1	10057-101H3	39.64	2.09	2.09
uterus, adult, pool1	10100-102D1	26.62	3.07	3.41
uterus, fetal, donor1	10055-101H1	28.67	9.21	6.66
vagina, adult	10204-103F6	19.39	1.94	1.94
vein, adult	10191-103E2	18.41	1.10	1.53
xeroderma pigentosum b cell line:XPL 17	10563-108A5	16.02	1.34	1.07